Rituximab in thrombotic microangiopathy

Br J Haematol. 2007 Oct;139(1):166; author reply 166-7. doi: 10.1111/j.1365-2141.2007.06767.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Microcirculation
  • Plasma Exchange
  • Postoperative Complications / drug therapy*
  • Rituximab
  • Thrombosis / drug therapy*
  • Unnecessary Procedures

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab